NDC80 and cancer: The expression of NDC80 complex components showed a significant and positive correlation with TP53 mutation in different cancer types, including ACC, BLCA, BRCA, KIRC, LIHC, LUAD, PRAD, SKCM, and UCEC (Figure 7A).